Sensus Healthcare Statistics
Share Statistics
Sensus Healthcare has 16.39M shares outstanding. The number of shares has increased by 0.04% in one year.
Shares Outstanding | 16.39M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.02% |
Owned by Institutions (%) | n/a |
Shares Floating | 13.27M |
Failed to Deliver (FTD) Shares | 197 |
FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 535.65K, so 3.27% of the outstanding shares have been sold short.
Short Interest | 535.65K |
Short % of Shares Out | 3.27% |
Short % of Float | 4.04% |
Short Ratio (days to cover) | 6.14 |
Valuation Ratios
The PE ratio is 79.12 and the forward PE ratio is 12.09. Sensus Healthcare 's PEG ratio is 0.04.
PE Ratio | 79.12 |
Forward PE | 12.09 |
PS Ratio | 1.57 |
Forward PS | 3 |
PB Ratio | 0.79 |
P/FCF Ratio | -16.16 |
PEG Ratio | 0.04 |
Enterprise Valuation
Sensus Healthcare Inc. has an Enterprise Value (EV) of 16.01M.
EV / Earnings | 33 |
EV / Sales | 0.66 |
EV / EBITDA | 202.62 |
EV / EBIT | -41.9 |
EV / FCF | -6.74 |
Financial Position
The company has a current ratio of 11.76, with a Debt / Equity ratio of 0.
Current Ratio | 11.76 |
Quick Ratio | 8.94 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0.38 |
Cash Flow / Debt | -11.47 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.01% and return on capital (ROIC) is -0.57%.
Return on Equity (ROE) | 0.01% |
Return on Assets (ROA) | 0.01% |
Return on Capital (ROIC) | -0.57% |
Revenue Per Employee | 697.29K |
Profits Per Employee | 13.86K |
Employee Count | 35 |
Asset Turnover | 0.45 |
Inventory Turnover | 0.87 |
Taxes
Income Tax | 167.00K |
Effective Tax Rate | 0.26 |
Stock Price Statistics
The stock price has increased by 242.08% in the last 52 weeks. The beta is 1.04, so Sensus Healthcare 's price volatility has been higher than the market average.
Beta | 1.04 |
52-Week Price Change | 242.08% |
50-Day Moving Average | 7.38 |
200-Day Moving Average | 5.7 |
Relative Strength Index (RSI) | 57.55 |
Average Volume (20 Days) | 162.42K |
Income Statement
In the last 12 months, Sensus Healthcare had revenue of $24.41M and earned $485.00K in profits. Earnings per share was $0.03.
Revenue | 24.41M |
Gross Profit | 14.06M |
Operating Income | -382.00K |
Net Income | 485.00K |
EBITDA | 79.00K |
EBIT | -382.00K |
Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has $23.15M in cash and $783.00K in debt, giving a net cash position of $22.36M.
Cash & Cash Equivalents | 23.15M |
Total Debt | 783.00K |
Net Cash | 22.36M |
Retained Earnings | 6.79M |
Total Assets | 59.86M |
Working Capital | 49.60M |
Cash Flow
In the last 12 months, operating cash flow was -$2.15M and capital expenditures -$229.00K, giving a free cash flow of -$2.37M.
Operating Cash Flow | -2.15M |
Capital Expenditures | -229.00K |
Free Cash Flow | -2.37M |
FCF Per Share | -0.15 |
Margins
Gross margin is 57.61%, with operating and profit margins of -1.57% and 1.99%.
Gross Margin | 57.61% |
Operating Margin | -1.57% |
Pretax Margin | 2.67% |
Profit Margin | 1.99% |
EBITDA Margin | 0.32% |
EBIT Margin | -1.57% |
FCF Margin | -9.73% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 0.37% |
FCF Yield | -1.77% |
Analyst Forecast
The average price target for SRTS is $12.5, which is 52.3% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.5 |
Price Target Difference | 52.3% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Scores
Altman Z-Score | 17.21 |
Piotroski F-Score | 6 |